What Modified Checklist for Autism in Todler (mCHAT) score is concerning?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Concerning M-CHAT Scores for Autism Screening

An M-CHAT score of 3 or higher initially, and 2 or higher after follow-up interview, is concerning and warrants referral for diagnostic evaluation, as this indicates a 47.5% risk of autism spectrum disorder (ASD) and a 94.6% risk of any developmental delay. 1

Understanding M-CHAT Scoring and Risk Levels

The Modified Checklist for Autism in Toddlers (M-CHAT) is a validated screening tool used primarily for toddlers between 16-30 months of age. Based on the most recent evidence, the M-CHAT-R/F (Revised with Follow-up) uses a three-tier risk stratification system:

Risk Categories:

  • Low Risk (0-2 points): Continue routine developmental surveillance
  • Medium Risk (3-7 points): Administer follow-up interview; refer for diagnostic evaluation if score remains ≥2 after follow-up
  • High Risk (8-20 points): Bypass follow-up interview and refer immediately for diagnostic evaluation 1

Clinical Significance of M-CHAT Scores

The positive predictive value (PPV) of the M-CHAT varies significantly based on:

  1. Age of screening:

    • PPV is lower in younger children (16-23 months): 0.28
    • PPV is higher in older children (24-30 months): 0.61 2
  2. Risk status:

    • Low-risk population: PPV = 0.11 without follow-up; improves to 0.65 with follow-up interview
    • High-risk population: PPV = 0.60 without follow-up; improves to 0.76 with follow-up interview 2
  3. Follow-up interview impact:

    • The follow-up interview is essential as it significantly improves PPV and reduces false positives
    • In the largest sample to date (N=18,989), PPV for ASD with follow-up was 0.54, and for any developmental disorder was 0.98 2

Implementation Recommendations

Optimal Screening Protocol:

  1. Initial screening: Administer M-CHAT-R at 18 and 24-month well-child visits
  2. Risk stratification:
    • Score 0-2: Low risk, continue routine monitoring
    • Score 3-7: Medium risk, conduct follow-up interview
    • Score ≥8: High risk, refer directly for evaluation 1
  3. After follow-up interview:
    • If score remains ≥2: Refer for diagnostic evaluation
    • If score <2: Low risk, continue routine monitoring

Important Clinical Considerations:

  • Children with initial scores of 3-7 (93% of all cases) require the follow-up interview
  • Children with scores ≥8 (1% of all cases) should be referred directly for diagnostic assessment 2
  • The follow-up interview is critical as it reduces false positives while maintaining sensitivity

Pitfalls and Caveats

  • Age considerations: M-CHAT may be less accurate at 18 months compared to 24 months 3
  • False negatives: Some children with ASD may be missed by M-CHAT screening, particularly those with more subtle presentations
  • Cultural factors: Validation studies in different populations show varying PPVs (e.g., 0.19 in a Spanish sample) 2
  • Developmental context: A positive M-CHAT may detect not only ASD but also other developmental delays, speech delays, and social anxiety 4
  • Follow-up completion: In implementation studies, only about 60-63% of screen-positive children completed diagnostic evaluations 2

Benefits of Early Detection

Early identification through M-CHAT screening can lower the age of ASD diagnosis by approximately 2 years compared to national averages, significantly increasing the time available for early intervention 1. In one implementation study, children were diagnosed at a mean age of 24 months following M-CHAT screening 4, which is substantially earlier than typical diagnosis ages.

Remember that while M-CHAT is a valuable screening tool, it is not diagnostic, and all children with concerning scores should be referred for comprehensive evaluation by specialists in ASD diagnosis.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.